Moberg Pharma AB (MBGPF)
1.08
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Moberg Pharma Net Income (Quarterly) : -0.3504M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3504M |
| March 31, 2026 | -0.1382M |
| December 31, 2025 | -1.356M |
| September 30, 2025 | -0.4536M |
| June 30, 2025 | -0.7649M |
| March 31, 2025 | -0.2595M |
| December 31, 2024 | -22.57M |
| September 30, 2024 | -0.121M |
| June 30, 2024 | -0.3785M |
| March 31, 2024 | -0.625M |
| December 31, 2023 | -0.6041M |
| September 30, 2023 | -0.5333M |
| June 30, 2023 | -0.3654M |
| March 31, 2023 | -0.4818M |
| December 31, 2022 | -0.2903M |
| September 30, 2022 | -0.4028M |
| June 30, 2022 | -0.3965M |
| March 31, 2022 | -0.4755M |
| December 31, 2021 | -0.4556M |
| September 30, 2021 | -0.4522M |
| June 30, 2021 | -0.3951M |
| March 31, 2021 | -0.5891M |
| December 31, 2020 | -0.5974M |
| September 30, 2020 | -0.5262M |
| June 30, 2020 | -0.5407M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3515M |
| June 30, 2019 | -0.8045M |
| March 31, 2019 | 0.3131M |
| December 31, 2018 | 1.212M |
| September 30, 2018 | |
| June 30, 2018 | -1.014M |
| March 31, 2018 | -0.975M |
| December 31, 2017 | 1.150M |
| September 30, 2017 | 1.519M |
| June 30, 2017 | -0.8825M |
| March 31, 2017 | -0.3367M |
| December 31, 2016 | -0.2737M |
| September 30, 2016 | 1.502M |
| June 30, 2016 | 3.407M |
| March 31, 2016 | -0.6676M |
| December 31, 2015 | 0.046M |
| September 30, 2015 | 1.034M |
| June 30, 2015 | 0.6486M |
| March 31, 2015 | 1.308M |
| December 31, 2014 | -0.0355M |
| September 30, 2014 | 0.6324M |
| June 30, 2014 | 0.6163M |
| March 31, 2014 | 0.6297M |
| December 31, 2013 | -0.0655M |
| September 30, 2013 | -0.599M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Orexo AB | -10.95M |
| Swedencare AB | 2.531M |
| Camurus AB | 25.72M |
| Infant Bacterial Therapeutics AB | -3.175M |
| AstraZeneca PLC | 3.076B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.6157M |
| Total Expenses (Quarterly) | 0.9661M |
| EPS Diluted (Quarterly) | -0.0075 |
| Enterprise Value | 29.18M |
| Gross Profit Margin (Quarterly) | 65.36% |
| Profit Margin (Quarterly) | -56.91% |
| Earnings Yield | -4.54% |
| Normalized Earnings Yield | -4.528 |